Design and synthesis of 3′- and 5′-O-(3-benzenesulfonylfuroxan-4-yl)-2′-deoxyuridines:: Biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents

Design and synthesis of 3′- and 5′-O-(3-benzenesulfonylfuroxan-4-yl)-2′-deoxyuridines:: Biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents
复制标题

DOI:
10.1021/jm030544m
复制
发表时间:
2004-03-25
影响因子:
7.3
通讯作者:
Knaus, EE
Knaus, EE
中科院分区:
医学1区
文献类型:
--
作者:
Moharram, S;Zhou, A;Knaus, EE

文献摘要

被引文献

相似文献

合成了一组在核苷部分的 C-5 位具有多种取代基(H、Me、1、F、CF3)的 3'-O- 和 5'-O-(3-苯磺酰基呋喃氧烷-4-基)-2'-脱氧尿苷,用于评估作为能够同时释放细胞毒性一氧化氮的混合抗癌剂 ((NO)-N-。)。在 18 MM L-半胱氨酸存在下孵育这些一氧化氮供体-核苷缀合物,释放出高百分比的 (NO)-N-。 (1 小时时为 21-48%;16 小时时为 37-86%)。 (NO)-N-的释放。在没有硫醇辅助因子的情况下可以忽略不计。这些杂合体(NO)-N-。供体核苷对一系列肿瘤细胞系(143B-LTK、14313、EMT-6、KBALB-STK 和 KBALB)和正常人成纤维细胞(Hs578Bst)表现出高细胞毒性(CC50 = 10(-6)-10(-8) M 范围)。未观察到具有 1 型单纯疱疹病毒 (HSV-1) 胸苷激酶基因 (TK+) 的未转染 (143B、KBALB) 和相应转染 (143B-LTK、KBALB-STK) 癌细胞系之间的细胞毒性差异,表明病毒 TK 酶的表达没有提供基因治疗效果。
A group of 3'-O- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines possessing a variety of substituents (H, Me, 1, F, CF3) at the C-5 position of the nucleoside moiety were synthesized for evaluation as hybrid anticancer agents that have the ability to simultaneously release cytotoxic nitric oxide ((NO)-N-.). Incubation of these nitric oxide donor-nucleoside conjugates in the presence of 18 MM L-cysteine released a high percentage of (NO)-N-. (21-48% at 1 h; 37-86% at 16 h). The release of (NO)-N-. in the absence of the thiol cofactor was negligible. These hybrid (NO)-N-. donor-nucleosides exhibited high cellular toxicity (CC50 = 10(-6)-10(-8) M range) against a battery of tumor cell lines (143B-LTK, 14313, EMT-6, KBALB-STK, and KBALB) and normal human fibroblasts (Hs578Bst). No differences in cytotoxicity between nontransfected (143B, KBALB) and the corresponding transfected (143B-LTK, KBALB-STK) cancer cell lines possessing the herpes simplex virus type 1 (HSV-1) thymidine kinase gene (TK+) were observed, indicating that expression of the viral TK enzyme did not provide a gene therapeutic effect.